For many, non-surgical treatments offer a less invasive alternative, but when dramatic change is needed, surgery remains the gold standard
(2) This indefinite decrease is known as somatopause and is associated with difficulty losing weight, bone mineral density loss, other age-related changes, and multiple health risks
"Supplements may appear to be a quick fix, but they are rarely effective on their own and can distract from more sustainable, evidence-based care
Efficacy and safety of co-administered once-weekly cagrilintide 24 mg with once-weekly GLP-3 24 mg in type 2 diabetes
Ongoing medical follow-up helps manage dosing and side effects
The potential role of GLP-1 agonists in treating alcohol use disorder (AUD) has emerged from both animal studies and early-phase human trials, though it is important to emphasise that there is no official licence for these medications in AUD treatment in the UK or elsewhere